The prognostic role of "drug score" on the outcome of advanced cancer patients treated with immune checkpoint inhibitors

被引：0
|
作者：
Perrone, F. [1 ]
Bersanelli, M. [1 ]
Cortellini, A. [2 ]
Casartelli, C. [1 ]
Bordi, P. [1 ]
Tiseo, M. [1 ]
Buti, S. [1 ]
机构：
[1] Univ Hosp Parma, Med Oncol Unit, Parma, Italy
[2] St Salvatore Hosp, Med Oncol Unit, Laquila, Italy
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.1160
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1040P
引用
收藏
页码：S714 / S715
页数：2
相关论文
共 50 条
  • [1] The Prognostic Role of High Blood Cholesterol in Advanced Cancer Patients Treated With Immune Checkpoint Inhibitors
    Perrone, Fabiana
    Minari, Roberta
    Bersanelli, Melissa
    Bordi, Paola
    Tiseo, Marcello
    Favari, Elda
    Sabato, Roberto
    Buti, Sebastiano
    JOURNAL OF IMMUNOTHERAPY, 2020, 43 (06) : 196 - 203
  • [2] Nutritional status as prognostic factor of advanced oesophageal cancer patients treated with immune checkpoint inhibitors
    Chen, Ning
    Yu, Ying
    Shen, Wanji
    Xu, Xiaoling
    Fan, Yun
    CLINICAL NUTRITION, 2024, 43 (01) : 142 - 153
  • [3] Sarcopenia Was a Poor Prognostic Predictor for Patients With Advanced Lung Cancer Treated With Immune Checkpoint Inhibitors
    Li, Shuluan
    Liu, Zhou
    Ren, Ya
    Liu, Jinying
    Lv, Shiqi
    He, Pin
    Yang, Yajing
    Sun, Yanfen
    Chang, Jianhua
    Luo, Dehong
    Cong, Minghua
    FRONTIERS IN NUTRITION, 2022, 9
  • [4] Hyperprogressive disease in patients with advanced cancer treated with immune checkpoint inhibitors
    Sen, Gulin Alkan
    Oztas, Nihan Senturk
    Degerli, Ezgi
    Guliyev, Murad
    Can, Guenay
    Turna, Hande
    Ozguroglu, Mustafa
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (12): : 3264 - 3271
  • [5] Development and validation of a immunotherapy prognostic score (IPS) for patients with advanced lung cancer treatedwith immune checkpoint inhibitors
    Hopkins, Ashley M.
    Kichenadasse, Ganessan
    Karapetis, Chris S.
    Rowland, Andrew
    Sorich, Michael J.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 83 - 83
  • [6] Prognostic Value of the Lung Immune Prognosis Index Score for Patients Treated with Immune Checkpoint Inhibitors for Advanced or Metastatic Urinary Tract Carcinoma
    Parent, Pauline
    Auclin, Edouard
    Patrikidou, Anna
    Mezquita, Laura
    Chanza, Nieves Martinez
    Dumont, Clement
    Rodriguez-Vida, Alejo
    Llacer, Casilda
    Lozano, Rebeca
    Ratta, Raffaele
    Merseburger, Axel S.
    Sternberg, Cora N.
    Baciarello, Giulia
    Colomba, Emeline
    Fuerea, Alina
    Besse, Benjamin
    Loriot, Yohann
    Lavaud, Pernelle
    CANCERS, 2023, 15 (04)
  • [7] Prognostic nutritional index as a prognostic biomarker for gastrointestinal cancer patients treated with immune checkpoint inhibitors
    Zhang, Lilong
    Ma, Wangbin
    Qiu, Zhendong
    Kuang, Tianrui
    Wang, Kunpeng
    Hu, Baohong
    Wang, Weixing
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [8] Association of the pretreatment lung immune prognostic index with survival outcomes in advanced gastric cancer patients treated with immune checkpoint inhibitors
    Hou, Baicun
    Wang, Peng
    Liu, Tingting
    Chen, Shixue
    Li, Tao
    Zhang, Sujie
    Tao, Haitao
    Li, Xiaoyan
    Hu, Yi
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2021, 45 (05)
  • [9] Baseline IPI (immune prognostic index) predicts survival in patients with advanced cervical cancer treated with immune checkpoint inhibitors (ICI)
    Blanc-Durand, F.
    Richardson, M.
    Vuagnat, P.
    Pautier, P.
    Hollebecque, A.
    Varga, A.
    Massard, C.
    Leary, A.
    ANNALS OF ONCOLOGY, 2019, 30
  • [10] The Khorana score and risk of venous thromboembolism in patients with cancer treated with immune checkpoint inhibitors
    Overvad, T. F.
    Ording, A. G.
    Nielsen, P. B.
    Piazza, G.
    Noble, S.
    Larsen, T. B.
    Skjoth, F.
    THROMBOSIS RESEARCH, 2022, 213 : S4 - S5
12345